| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/14/2008 | US20080038193 Antibodies for use in targeted and temporary treatment of humans and animals |
| 02/14/2008 | DE102006037724A1 Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices Use of ascorbic acid for the functionalization of matrices |
| 02/14/2008 | CA2660615A1 G-csf site-specific mono-conjugates |
| 02/14/2008 | CA2660427A1 Pharmaceutical composition |
| 02/14/2008 | CA2659809A1 Long half-life recombinant butyrylcholinesterase |
| 02/14/2008 | CA2658549A1 Oral disintegrating tablet having masked bitter taste and method for production thereof |
| 02/14/2008 | CA2646901A1 Formulations for parenteral delivery of compounds and uses thereof |
| 02/13/2008 | EP1887082A2 TADG-15: An extracellular serine protease overexpressed in carcinomas |
| 02/13/2008 | EP1887015A2 Method for extracting and using new human defence agents and biologically active proteins for treating infections and other illnesses |
| 02/13/2008 | EP1886696A1 Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins |
| 02/13/2008 | EP1886693A1 Agent for regeneration and/or protection of nerves |
| 02/13/2008 | EP1886688A1 Method for producing nucleic acid-containing complex preparation |
| 02/13/2008 | EP1886686A1 Pharmaceutical composition containing mometasone furoate |
| 02/13/2008 | EP1886681A2 New nuclear transcription factors regulators |
| 02/13/2008 | EP1886678A1 Stable tablet containing droxidopa |
| 02/13/2008 | EP1886675A1 Skin patch |
| 02/13/2008 | EP1886673A2 Solid dosage form of enteric solid dispersion and method for producing the same |
| 02/13/2008 | EP1886672A2 Solid dosage form comprising solid dispersion and method for producing the same |
| 02/13/2008 | EP1886671A1 Starch silica co-precipitate, method for preparing the same and use thereof |
| 02/13/2008 | EP1886668A1 Controlled release compositions for interferon based on block polymers |
| 02/13/2008 | EP1886667A1 Microemulsified drug formulation |
| 02/13/2008 | EP1885768A1 New poly(ethylene glycol) derivatives and process for their coupling to proteins |
| 02/13/2008 | EP1885742A1 Compositions for targeting amine oxidases in vivo |
| 02/13/2008 | EP1885404A2 Bioconjugation reactions for acylating polyethlene glycol reagents |
| 02/13/2008 | EP1885403A2 Polyethylene glycol cojugates of antimicrobial agents |
| 02/13/2008 | EP1885374A2 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form |
| 02/13/2008 | EP1885373A2 Use of a clobetasol spray formulation for the treatment of psoriasis |
| 02/13/2008 | EP1885345A1 Thin foam coating comprising discrete, closed-cell capsules |
| 02/13/2008 | EP1885332A2 Use of an artificial sweetener to enhance absorption of nicotine |
| 02/13/2008 | EP1885203A2 Methods for promoting health or wellness in adult animals |
| 02/13/2008 | EP1617827B1 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances |
| 02/13/2008 | EP1606349B1 Controlled release polymeric gels |
| 02/13/2008 | EP1578785B1 Peptides that bind to the heparin binding domain of vegf and vegfr-2 |
| 02/13/2008 | EP1569665A4 Composition and method for mammary disinfection during winter conditions |
| 02/13/2008 | EP1569664B1 Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them |
| 02/13/2008 | EP1553940B1 Parenteral formulations containing a rapamycin hydroxyester |
| 02/13/2008 | EP1490025B1 Nanoparticulate compositions of map kinase inhibitors |
| 02/13/2008 | EP1441701B1 Montelukast granule formulation |
| 02/13/2008 | EP1436010B1 Water-in-oil emulsions comprising vinyl polymers carrying ethylene oxide groups in side chains, compositions, and methods |
| 02/13/2008 | EP1427397B1 Oily thixotropic formulations |
| 02/13/2008 | EP1411923B1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 02/13/2008 | EP1335747B1 A composition of sodium channel blocking compound |
| 02/13/2008 | EP1297843B1 Method of photoreduction of hemoglobin vesicles |
| 02/13/2008 | EP1233770B1 Phosphonate compounds |
| 02/13/2008 | EP1168934B1 Hydrogel-forming system with hydrophobic and hydrophilic components |
| 02/13/2008 | EP1140022B1 Method of administering a compound to multi-drug resistant cells |
| 02/13/2008 | EP1105467B9 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 02/13/2008 | EP1001751B1 Aqueous viscous compositions, whether clear or not, for making soft or hard capsules, and method for making films for such capsules |
| 02/13/2008 | EP0758244B2 Controlled-release dosage forms of azithromycin |
| 02/13/2008 | CN101124343A Apparatus and method for transdermal delivery of influenza vaccine |
| 02/13/2008 | CN101124276A Water-dispersible xanthan gum containing composition |
| 02/13/2008 | CN101123992A Derivatives of insulinotropic agents conjugated with structurally well defined branched polymers |
| 02/13/2008 | CN101123991A Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol) |
| 02/13/2008 | CN101123990A Nanoparticles comprising antigens and adjuvants and immunogenic structure |
| 02/13/2008 | CN101123989A A process for the preparation of a piroxicam: betacyclodextrin inclusion compound |
| 02/13/2008 | CN101123988A Sustained release composition of protein drug |
| 02/13/2008 | CN101123987A Dialysis preparation |
| 02/13/2008 | CN101123986A Glucocerebroside treatment of disease |
| 02/13/2008 | CN101123967A Transdermal administration of phycotoxins |
| 02/13/2008 | CN101123948A 眼科用固体外用药剂 Topical ophthalmic pharmaceutical solid |
| 02/13/2008 | CN101123942A Hyaluronic acid fraction with moisturizing and anti-wrinkle properties |
| 02/13/2008 | CN101123936A Oral compositions containing oxidized camellia |
| 02/13/2008 | CN101121821A Three kinds of polycarboxylphenoxyphosphazene/glutin composite hydrogel and application thereof |
| 02/13/2008 | CN101121750A Humanized anti-erbb2 antidbodies and treatment with anti-erbb2 antibodies |
| 02/13/2008 | CN101121676A Water gelling agent used for forming supermolecule hydrogel and preparation method thereof |
| 02/13/2008 | CN101121614A Preparation method and application for composite metal chelating chitose amine selenite and different dosage form thereof |
| 02/13/2008 | CN101121519A Hollow silicon dioxide sub-micron sphere with inner core and its preparation method and use |
| 02/13/2008 | CN101121022A Method for preparing optical dynamic drug carrier nano magnetic silica composite granules |
| 02/13/2008 | CN101121021A Humanized anti-ErbB2 antidbodies and treatment with anti-ErbB2 antibodies |
| 02/13/2008 | CN101121004A Medicine composition containing insulin intensifier and miglitol |
| 02/13/2008 | CN101120981A Traditional Chinese medicine preparation for treating fracture and wound and pain and preparation process thereof |
| 02/13/2008 | CN101120958A Medicinal preparation for treating liver cancer and leukemia and producing technology thereof |
| 02/13/2008 | CN101120955A Enteric coated preparation containing glossy ganoderma spore powder active ingredient |
| 02/13/2008 | CN101120948A Compound composition with chemical protecting, cancer preventing and treating use |
| 02/13/2008 | CN101120941A Methylcantharidimide injection and freeze-dried powder injection for treating tumor and preparation method thereof |
| 02/13/2008 | CN101120929A Gabapentin stomach retention sustained-release composition |
| 02/13/2008 | CN101120924A Calf serum protein-removing extract for injection and its preparation method |
| 02/13/2008 | CN101120923A Vitamin and mineral nutrient complementing granule or tablet for children and teen-agers, and preparation method thereof |
| 02/13/2008 | CN101120922A Solid dosage form comprising solid dispersion and method for producing the same |
| 02/13/2008 | CN101120920A Tegafur enous emulsion and preparation method thereof |
| 02/13/2008 | CN101120916A Prostaglandin E2 injection and manufacturing method thereof |
| 02/13/2008 | CN101120913A Ftibamzone chrisma with PEG-200 as co-solvent |
| 02/13/2008 | CN101120912A Ftibamzone chrisma with PEG-400 as co-solvent |
| 02/13/2008 | CN101120911A Ftibamzone chrisma with propanediol as co-solvent |
| 02/13/2008 | CN100368410C Micronized crystalline tiotropium bromide |
| 02/13/2008 | CN100368022C Medicine carrier pseudoglucoprotein nano particle of double-target anti-liver-fibrosis and its preparing method |
| 02/13/2008 | CN100368021C Ophthalmological anti proliferative medicine containing sodium alginate micro gel bead and convex membrane and preparing method |
| 02/13/2008 | CN100368020C Compositions for stimulating cytokine secretion and inducing an immune response |
| 02/13/2008 | CN100368019C Chitin-sodium alginate packed pylorus helicobacterium protein microballs and their preparation |
| 02/13/2008 | CN100368017C Compound bioogic component and pharmaceutical preparation possessing function for accelerating hemoglutination |
| 02/13/2008 | CN100368013C Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 02/13/2008 | CN100367964C Inclusion preparation of levosimendan and beta cyclodextrin |
| 02/13/2008 | CN100367962C Stable palonosetron injection liquid and its preparation method |
| 02/13/2008 | CN100367960C Process for producing coated preparation |
| 02/13/2008 | CN100367951C Butyl benzene phthalein vein emulsion and its application |
| 02/13/2008 | CN100367948C Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 02/13/2008 | CN100367945C Pharmaceutical microspheres of valproic acid for oral administration |
| 02/13/2008 | CN100367943C Propofol-containing fat emulsions |
| 02/13/2008 | CN100367930C Spontaneously dispersible N-benzoyl staurosporine compositions |
| 02/13/2008 | CN100367927C Drug delivery of phase changing formulation |